Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations

PURPOSE: In the interferon era of hepatitis C virus (HCV) therapies, genotype/subtype, cirrhosis, prior treatment failure, sex, and race predicted relapse. Our objective is to validate a targeted proteomics platform of 17 peptides to predict sustained virologic response (SVR). EXPERIMENTAL DESIGN: S...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Proteomics Clin Appl
Egile Nagusiak: Naggie, Susanna, Clement, Meredith, Lusk, Sam, Osinusi, Anu, Himmel, Tiffany, Lucas, Joseph E., Thompson, Will J., Dubois, Laura, Moseley, M. Arthur, Clark, Paul J., Kottilil, Shyam, Patel, Keyur
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353701/
https://ncbi.nlm.nih.gov/pubmed/30058111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201800006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak